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                                                    ABSTRACT 
 
BACKGROUND AND OBJECTIVES: 
Diabetes mellitus is a group of metabolic disorder characterised by 
chronic hyperglycemia associated with disturbance of carbohydrate, protein and 
fat metabolism. It causes long term damage and dysfunction to all the organs of 
the body especially kidneys, heart, eyes, nerves. Diabetes increases the 
frequency and severity of infections. Diabetes with sepsis contribute to around 
22% of total sepsis cases.HbA1c reflect the average concentration of plasma 
glucose over previous 3 months. This study aims at  whether HbA1c can be 
used as a prognostic factor in type 2 diabetes patients with sepsis. And to study 
the correlation of HbA1c with other factors like admission plasma glucose, 
CRP, APACHE II score, SOFA score, total leukocyte count and assessing the 
efficacy of HbA1c as a prognostic factor. 
METHODS: 
Patients admitted with diabetes and sepsis in the wards of department of 
medicine, Madras Medical College, Chennai  during the period of April 2016 to 
September 2016 were taken up for study considering the inclusion and 
exclusion criteria. 
 
 
RESULTS: 
       Out of 100 patients studied, 71 patients survived and 29 patients died. The 
majority of deaths were in patients aged above 60 yrs. Females have higher 
mortality rate than males.HbA1c is a good prognostic factor for assessing 
mortality in type 2 diabetes patients with sepsis. 
INTERPRETATION AND CONCLUSION: 
HbA1c ,APACHE II score, SOFA score, CRP, total leukocyte count were  
found to have significant correlation with 30 days mortality and length of 
hospitalisation. 
 Admission plasma glucose has no correlation with mortality and length of 
stay in our study. 
 HbA1c has correlation with CRP, APACHE  II score, SOFA score but 
not with admission plasma glucose levels. 
 HbA1c is as efficacious as both APACHE II score and SOFA score as a 
prognostic factor in diabetes patients with sepsis. 
